BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Affymax, Inc. 

4001 Miranda Avenue

Palo Alto  California  94304  U.S.A.
Phone: 650-812-8700 Fax: 650-424-0832


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Mosaic Technologies 





 Company News
Xstelos Announces Intention To Vote Against Affymax, Inc. (AFFY)'s Plan Of Liquidation At September 23, 2014 Special Meeting of Shareholders 9/22/2014 9:02:13 AM
Affymax, Inc. (AFFY) Reports Second Quarter 2014 Financial Results 8/1/2014 9:04:07 AM
Bay Area's Affymax, Inc. (AFFY) To Dissolve 6/24/2014 4:49:28 PM
Affymax, Inc. (AFFY) Drug Omontys® Terminal As Takeda Pharmaceutical Co. Ltd. (TKPYY) Switches Off Support 6/16/2014 10:49:39 AM
Affymax, Inc. (AFFY) Announces Update on Listing, Senior Leadership and Board Changes 6/7/2013 10:28:12 AM
Affymax, Inc. (AFFY) CEO Steps Down as Restructuring Firm Steps in 5/15/2013 8:57:51 AM
Affymax, Inc. (AFFY) Reports Fourth Quarter and Year-End 2012 Financial Results 4/2/2013 6:30:17 AM
Affymax, Inc. (AFFY) May File for Bankruptcy; Cuts 75 Pct of Workforce 3/19/2013 7:18:09 AM
Affymax, Inc. (AFFY) to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/7/2013 6:17:14 AM
The New England Journal of Medicine Publishes Pivotal Trial Data for Affymax, Inc. (AFFY), and Takeda Pharmaceuticals's OMONTYS® (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis 1/24/2013 9:01:03 AM
12345678910...